UNSPSC 51392415: Dopexamine hydrochloride

This classification denotes a dopamine agonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0VN909S60Y. European Medicines Agency schedules Dopexamine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01819MIG. Dopexamine hydrochloride generally arises in the molecular formula C22H32N2O2.2CLH. The term 'dopexamine hydrochloride' is a European Pharmacopoeia designation. Most nations, for tariff and trade purposes, schedule dopexamine hydrochloride under HS 29222900 and SITC 51462.

As of Q4 2014, DOPEXAMINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Dopexamine hydrochloride bears US NLM identifiers UMLS ID C0770936 and NCI Concept Code C76650. SMILES: C1CCC(CC1)CCNCCCCCCNCCC2CCC(C(C2)O)O.CL.CL.

UNSPSC 51392415 Dopexamine hydrochloride is a Commodity code that captures individual pharmaceutical products procured by state and local health agencies. However, the recent solicitation activity tagged under this code shows a material mismatch: Seminole County, Florida posted an IFB for naloxone and drug deactivation systems — products unrelated to dopexamine hydrochloride, a catecholamine medication used in acute cardiovascular care. The code appears to see limited recent activity aligned with its nominal scope, and the available opportunity reflects a misclassification rather than actual procurement demand for dopexamine itself.

Seminole County's IFB 60459723LAS (posted June 30, 2026, with response due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement required electronic bid submission, included shipping and delivery costs in proposals, mandated E-Verify compliance and drug-free workplace certification, and offered an initial two-year contract term with a one-year renewal option. The opportunity included potential FEMA funding with associated federal compliance requirements. Beyond this single posting, the source provides no additional recent opportunities, issuing-body patterns, or geographic spread data that would characterize genuine dopexamine procurement activity across state and local jurisdictions.